Home › Asset managers › Compare 2025-2026 › Equitable vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
Equitable 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 53,208 | 35,603 | 1,906 | 15,699 | 94.9% | 84.4% |
| Board proposals | 46,481 | 30,253 | 1,771 | 14,457 | 94.5% | 83.7% |
| E&S shareholder proposals | 201 | 10 | 2 | 189 | 83.3% | 43.3% |
| Other items | 6,526 | 5,340 | 133 | 1,053 | 97.6% | 90.3% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
15,699 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Equitable | Brighthouse |
|---|---|---|---|---|---|---|
| AB SAGAX | May 8, 2026 | REELECT DAVID MINDUS AS DIRECTOR Director Elections |
Board | For | Split 3 FOR, 4 AGAINST |
FOR 2 funds |
| AB SAGAX | May 8, 2026 | REELECT FILIP ENGELBERT AS DIRECTOR Director Elections |
Board | For | Split 3 FOR, 4 AGAINST |
AGAINST 2 funds |
| ABBOTT LABORATORIES | April 24, 2026 | Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees Compensation |
Board | For | FOR 20 funds |
Split 9 FOR, 3 AGAINST |
| ABBOTT LABORATORIES | April 24, 2026 | Election of 12 Directors: N. McKinstry Director Elections |
Board | For | Split 17 FOR, 1 AGAINST |
FOR 5 funds |
| ABBOTT LABORATORIES | April 24, 2026 | Election of 12 Directors: R. B. Ford Director Elections |
Board | For | Split 17 FOR, 1 AGAINST |
FOR 5 funds |
| ABBOTT LABORATORIES | April 24, 2026 | Ratification of Ernst & Young LLP As Auditors Audit-related |
Board | For | FOR 20 funds |
Split 9 FOR, 3 ABSTAIN |
| ABBOTT LABORATORIES | April 24, 2026 | Say on Pay - An Advisory Vote on the Approval of Executive Compensation Say-on-Pay |
Board | For | Split 19 FOR, 1 AGAINST |
Split 9 FOR, 3 ABSTAIN |
| ABBVIE INC. | May 8, 2026 | Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 Audit-related |
Board | For | FOR 25 funds |
Split 10 FOR, 4 ABSTAIN |
| ABBVIE INC. | May 8, 2026 | Say on Pay - An advisory vote on the approval of executive compensation Say-on-Pay |
Board | For | FOR 25 funds |
Split 9 FOR, 1 AGAINST, 4 ABSTAIN |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000. Compensation |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 1 fund |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 6 FOR, 1 AGAINST |
AGAINST 1 fund |
| ABERCROMBIE & FITCH CO. | June 3, 2026 | Advisory vote to approve the compensation of the Company's named executive officers for the fiscal year ended January 31, 2026. Say-on-Pay |
Board | For | FOR 10 funds |
Split 4 FOR, 2 ABSTAIN |
| ABERCROMBIE & FITCH CO. | June 3, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 30, 2027. Audit-related |
Board | For | FOR 10 funds |
Split 4 FOR, 2 ABSTAIN |
| ABM INDUSTRIES INCORPORATED | March 25, 2026 | Advisory approval of our executive compensation. Say-on-Pay |
Board | For | FOR 7 funds |
Split 3 FOR, 1 ABSTAIN |
| ABM INDUSTRIES INCORPORATED | March 25, 2026 | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 3 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: Art A. Garcia Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: Barry A. Hytinen Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: Carol A. Clements Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: Donald F. Colleran Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: James D. DeVries Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: Jill M. Golder Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: LeighAnne G. Baker Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: Quincy L. Allen Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: Scott Salmirs Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: Sudhakar Kesavan Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: Thomas M. Gartland Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABM Industries Incorporated | March 25, 2026 | Election of twelve director nominees to serve one-year terms: Winifred M. Webb Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ABSCI CORPORATION | June 4, 2026 | The election of the Class II directors nominated by the Board of Directors and named in the Proxy Statement to hold office for a three-year term expiring at our 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified. Prof Sir Menelas Pangalos, Ph.D. Director Elections |
Board | For | Split 5 FOR, 1 WITHHOLD |
WITHHOLD 1 fund |
| ACADEMY SPORTS AND OUTDOORS, INC. | June 4, 2026 | Approval, on a non-binding advisory basis, of the fiscal 2025 compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADEMY SPORTS AND OUTDOORS, INC. | June 4, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. Say-on-Pay |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. Compensation |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. Daly Director Elections |
Board | For | WITHHOLD 3 funds |
Split 3 FOR, 2 WITHHOLD |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA REALTY TRUST | May 13, 2026 | THE APPROVAL, ON A NON-BINDING ADVISORY BASIS, OF THE COMPENSATION OF NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE COMPANY'S 2026 PROXY STATEMENT. Say-on-Pay |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIA REALTY TRUST | May 13, 2026 | THE RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 7 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Andrew Kim Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Barbara Trebbi Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: John Paulson Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Kelly Young Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Robert Chersi Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Ratification of the appointment of KPMG LLP as the registered public accounting firm of Acadian Asset Management Inc. Audit-related |
Board | For | FOR 7 funds |
Split 2 FOR, 2 ABSTAIN |
| ACCEL ENTERTAINMENT, INC. | May 7, 2026 | Elect six (6) directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify. Karl Peterson Director Elections |
Board | For | FOR 5 funds |
Split 1 FOR, 1 WITHHOLD |
| ACCEL ENTERTAINMENT, INC. | May 7, 2026 | Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 1 FOR, 1 ABSTAIN |
| ACCELERANT HOLDINGS | May 12, 2026 | to consider and vote upon the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026; Audit-related |
Board | For | FOR 1 fund |
Split 1 FOR, 2 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Alan Jope Director Elections |
Board | For | FOR 24 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Arun Sarin Director Elections |
Board | For | FOR 24 funds |
Split 7 FOR, 1 AGAINST, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Jennifer Nason Director Elections |
Board | For | FOR 24 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Julie Sweet Director Elections |
Board | For | Split 23 FOR, 1 AGAINST |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Masahiko Uotani Director Elections |
Board | For | FOR 24 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Nancy McKinstry Director Elections |
Board | For | Split 22 FOR, 2 AGAINST |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Paula A. Price Director Elections |
Board | For | FOR 24 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Tracey T. Travis Director Elections |
Board | For | FOR 24 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan. Compensation |
Board | For | Split 24 FOR, 1 AGAINST |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To approve, in a non-binding vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 22 FOR, 3 AGAINST |
Split 7 FOR, 1 AGAINST, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To determine the price range at which Accenture can re-allot shares that it acquires as treasury shares under Irish law. Capital Structure |
Board | For | FOR 25 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To grant the Board of Directors the authority to issue shares under Irish law. Capital Structure |
Board | For | FOR 25 funds |
Split 8 FOR, 3 AGAINST |
| ACCENTURE PLC | January 28, 2026 | To grant the Board of Directors the authority to opt-out of pre-emption rights under Irish law. Capital Structure |
Board | For | Split 24 FOR, 1 AGAINST |
Split 8 FOR, 3 AGAINST |
| ACCENTURE PLC | January 28, 2026 | To ratify, in a non-binding vote, the appointment of KPMG LLP ("KPMG") as independent auditor of Accenture and to authorize, in a binding vote, the Audit Committee of the Board of Directors to determine KPMG's remuneration. Audit-related |
Board | For | Split 23 FOR, 1 AGAINST |
Split 7 FOR, 1 AGAINST |
| ACCIONA SA | June 24, 2026 | Reelect Jeronimo Marcos Gerard Rivero as Director Director Elections |
Board | For | Split 4 FOR, 4 AGAINST |
Split 2 FOR, 1 AGAINST |
| ACCIONA SA | June 24, 2026 | Reelect Maria Salgado Madrinan as Director Director Elections |
Board | For | Split 4 FOR, 4 AGAINST |
Split 2 FOR, 1 AGAINST |
| ACCIONA SA | June 24, 2026 | Reelect Teresa Sanjurjo Gonzalez as Director Director Elections |
Board | For | Split 4 FOR, 4 AGAINST |
Split 2 FOR, 1 AGAINST |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | Split 5 FOR, 2 AGAINST |
Split 2 FOR, 1 AGAINST |
| ACCOR SA | May 27, 2026 | Approve Remuneration Policy of Chairman and CEO Say-on-Pay |
Board | For | FOR 9 funds |
Split 1 FOR, 5 AGAINST |
| ACCOR SA | May 27, 2026 | Reelect Bruno Pavlovsky as Director Director Elections |
Board | For | Split 4 FOR, 4 AGAINST |
Split 5 FOR, 1 AGAINST |
| ACCURAY INCORPORATED | November 13, 2025 | To approve our 2026 Equity Incentive Plan. Compensation |
Board | For | Split 5 FOR, 1 AGAINST |
FOR 2 funds |
| ACCURAY INCORPORATED | November 13, 2025 | To conduct an advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 1 FOR, 1 ABSTAIN |
| ACCURAY INCORPORATED | November 13, 2025 | To elect three Class I directors named in the accompanying proxy statement to serve until our 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. Anne B. Le Grand Director Elections |
Board | For | FOR 5 funds |
Split 1 FOR, 1 ABSTAIN |
| ACCURAY INCORPORATED | November 13, 2025 | To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 1 FOR, 1 ABSTAIN |
| ACI WORLDWIDE, INC. | June 2, 2026 | To elect the nine directors named in the accompanying proxy statement to our Board of Directors to hold office until the 2027 Annual Meeting of Stockholders; Adalio T. Sanchez Director Elections |
Board | For | FOR 8 funds |
Split 4 FOR, 3 ABSTAIN |
| ACI WORLDWIDE, INC. | June 2, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026; Audit-related |
Board | For | FOR 8 funds |
Split 4 FOR, 3 ABSTAIN |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | Split 5 FOR, 1 AGAINST |
Split 2 AGAINST, 2 ABSTAIN |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Aclaris Therapeutics, Inc. for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 2 FOR, 2 ABSTAIN |
| ACM RESEARCH, INC. | June 10, 2026 | Ratification of appointment of Ernst & Young Hua Ming LLP as independent auditor for year 2026. Audit-related |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: Charles Pappis Director Elections |
Board | For | Split 3 FOR, 2 WITHHOLD |
WITHHOLD 2 funds |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: David H. Wang Director Elections |
Board | For | Split 3 FOR, 2 WITHHOLD |
WITHHOLD 3 funds |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: Haiping Dun Director Elections |
Board | For | Split 3 FOR, 2 WITHHOLD |
Split 2 FOR, 1 WITHHOLD |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: Tracy Liu Director Elections |
Board | For | Split 3 FOR, 2 WITHHOLD |
WITHHOLD 3 funds |
| ACS, ACTIVIDADES DE CONSTRUCCION Y SERVICIOS SA | May 7, 2026 | Advisory Vote on Remuneration Report Say-on-Pay |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 3 funds |
| ACS, ACTIVIDADES DE CONSTRUCCION Y SERVICIOS SA | May 7, 2026 | Approve Restricted Stock Plan and Stock Option Plan Compensation |
Board | For | Split 7 FOR, 1 ABSTAIN |
FOR 3 funds |
| ACUITY INC. | January 21, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| ACUITY INC. | January 21, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | Split 8 FOR, 1 AGAINST |
Split 3 FOR, 1 ABSTAIN |
| ACUSHNET HOLDINGS CORP. | June 8, 2026 | To approve, in a non-binding advisory vote, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 3 FOR, 1 ABSTAIN |
| ACUSHNET HOLDINGS CORP. | June 8, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 3 FOR, 1 ABSTAIN |
| ACV AUCTIONS INC. | May 27, 2026 | Elect the two Class II directors named in this Proxy Statement: Brian Hirsch Director Elections |
Board | For | Split 3 FOR, 2 WITHHOLD |
FOR 2 funds |
| ACV AUCTIONS INC. | May 27, 2026 | Elect the two Class II directors named in this Proxy Statement: Eileen Kamerick Director Elections |
Board | For | Split 3 FOR, 2 WITHHOLD |
WITHHOLD 2 funds |
| ACV AUCTIONS INC. | May 27, 2026 | Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 Audit-related |
Board | For | FOR 6 funds |
Split 2 FOR, 1 ABSTAIN |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | FOR 7 funds |
Split 3 FOR, 1 ABSTAIN |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders. Robert Hershberg, PhD, MD Director Elections |
Board | For | FOR 4 funds |
Split 1 FOR, 1 WITHHOLD |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026; Audit-related |
Board | For | FOR 7 funds |
Split 3 FOR, 1 ABSTAIN |
| ADDUS HOMECARE CORPORATION | June 10, 2026 | To approve, on an advisory, non-binding basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 2 ABSTAIN |
| ADDUS HOMECARE CORPORATION | June 10, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 4 FOR, 2 ABSTAIN |
| ADEIA INC. | May 7, 2026 | To approve an amendment to the Amended and Restated 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by an additional 10,700,000 shares of common stock; and Compensation |
Board | For | FOR 9 funds |
Split 4 FOR, 1 AGAINST |
| ADIDAS AG | May 7, 2026 | APPROVE MANAGEMENT BOARD REMUNERATION POLICY Say-on-Pay |
Board | For | AGAINST 8 funds |
Split 1 FOR, 2 AGAINST |
| ADIDAS AG | May 7, 2026 | REELECT IAN GALLIENNE TO THE SUPERVISORY BOARD Director Elections |
Board | For | Split 4 FOR, 3 AGAINST |
FOR 3 funds |
| ADIDAS AG | May 7, 2026 | REELECT NASSEF SAWIRIS TO THE SUPERVISORY BOARD Director Elections |
Board | For | Split 4 FOR, 3 AGAINST |
Split 1 FOR, 2 AGAINST |
← Previous Page 14 of 157 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.